Last Price$371.8(1.5%)
Market Cap$22.2B
P/EBITDA LTM
21.1x
5Y avg
19.1x
Medical - Diagnostics & Research industry
median
(0.7x)
Stock quality & Intrinsic value
6/10
(0.4%) overvalued
Waters Corporation P/EBITDA LTM
Annual
Quarterly
Daily
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/EBITDA LTM | 26.2x | 13.6x | 14.7x | 23.6x | 7.5x | 13.9x | 15.5x | 12.3x | 13.3x | 15.2x | 15.5x | 18.9x | 16.4x | 19.8x | 16.5x | 19.1x | 19.9x | 23.4x | 20.4x | 19.6x |
Overvalued or undervalued?
Check the intrinsic value for WAT
and see if it's the right time to invest.
Waters Corporation (WAT) P/EBITDA LTM comparison analysis
General
LTM P/EBITDA LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Waters CorporationWAT
22.5x
(0.5%)
(7.9%)
21.7%
Median Peer Set
19.2x
(0.1%)
2.4%
14.0%
IDEXX Laboratories, Inc.IDXX
29.2x
8.7%
25.2%
23.1%
Danaher CorporationDHR
22.4x
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc.A
22.1x
(4.7%)
5.0%
19.8%
Mettler-Toledo International Inc.MTD
21.9x
2.2%
12.7%
22.3%
Thermo Fisher Scientific Inc.TMO
19.2x
(4.6%)
(12.4%)
14.0%
Quest Diagnostics IncorporatedDGX
11.2x
(6.4%)
(6.5%)
9.2%
IQVIA Holdings Inc.IQV
9.9x
2.8%
2.4%
8.9%
Illumina, Inc.ILMN
(16.6x)
(2.9%)
4.6%
(28.0%)
Natera, Inc.NTRA
(113.7x)
32.0%
(32.1%)
(40.2%)
WAT key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,104.5 0.0% | 1,158.2 4.9% | 1,280.2 10.5% | 1,473.0 15.1% | 1,575.1 6.9% | 1,498.7 (4.9%) | 1,643.4 9.7% | 1,851.2 12.6% | 1,843.6 (0.4%) | 1,904.2 3.3% | 1,989.3 4.5% | 2,042.3 2.7% | 2,167.4 6.1% | 2,309.1 6.5% | 2,419.9 4.8% | 2,406.6 (0.6%) | 2,365.4 (1.7%) | 2,785.9 17.8% | 2,972.0 6.7% | 2,956.4 (0.5%) |
| Cost of Goods Sold (COGS) | 454.8 | 478.4 | 536.2 | 631.1 | 661.3 | 594.9 | 653.3 | 730.5 | 737.6 | 783.5 | 824.9 | 842.7 | 891.5 | 947.1 | 992.6 | 1,010.7 | 1,006.7 | 1,156.5 | 1,248.2 | 1,195.2 |
% margin | 649.7 58.8% | 679.9 58.7% | 744.0 58.1% | 841.9 57.2% | 913.9 58.0% | 903.8 60.3% | 990.1 60.2% | 1,120.7 60.5% | 1,106.0 60.0% | 1,120.8 58.9% | 1,164.4 58.5% | 1,199.7 58.7% | 1,276.0 58.9% | 1,362.0 59.0% | 1,427.4 59.0% | 1,395.9 58.0% | 1,358.7 57.4% | 1,629.3 58.5% | 1,723.8 58.0% | 1,761.2 59.6% |
| Operating Expenses | 364.9 | 396.7 | 440.4 | 493.0 | 524.1 | 509.2 | 540.1 | 592.1 | 587.1 | 603.4 | 631.1 | 624.4 | 648.1 | 684.0 | 688.0 | 687.4 | 705.1 | 802.5 | 840.6 | 943.5 |
| Research & Development Expenses (R&D) | 65.2 | 66.9 | 77.3 | 80.6 | 81.6 | 77.2 | 84.3 | 92.3 | 96.0 | 100.5 | 107.7 | 118.5 | 125.2 | 132.6 | 143.4 | 143.0 | 140.8 | 168.4 | 176.2 | 174.9 |
| Selling, General & Administrative Expenses (SG&A) | 300.2 | 321.7 | 357.7 | 403.7 | 426.7 | 421.4 | 445.5 | 490.0 | 477.3 | 493.0 | 512.7 | 495.7 | 513.0 | 544.7 | 536.9 | 534.8 | 553.7 | 627.0 | 658.0 | 736.0 |
% margin | 284.9 25.8% | 283.2 24.4% | 295.2 23.1% | 348.9 23.7% | 389.8 24.7% | 394.6 26.3% | 449.9 27.4% | 528.6 28.6% | 511.5 27.7% | 517.3 27.2% | 517.9 26.0% | 567.5 27.8% | 624.3 28.8% | 661.9 28.7% | 739.8 30.6% | 708.5 29.4% | 645.5 27.3% | 821.7 29.5% | 873.4 29.4% | 817.7 27.7% |
| Interest Income | 0.0 | 19.3 | 0.0 | 0.0 | 0.0 | 3.0 | 1.9 | 2.6 | 4.2 | 4.4 | 7.0 | 10.7 | 20.7 | 36.1 | 38.8 | 22.1 | 16.3 | 12.2 | 11.0 | 16.6 |
| Interest Expense | 0.0 | 8.6 | 32.2 | 25.7 | 17.6 | 8.0 | 12.1 | 19.3 | 23.9 | 25.7 | 27.2 | 25.5 | 24.2 | 20.8 | 9.8 | 26.6 | 32.8 | 32.7 | 37.8 | 98.9 |
| Pre-tax Income | 285.7 | 274.6 | 263.0 | 323.2 | 372.2 | 386.7 | 437.9 | 509.3 | 487.6 | 490.1 | 490.7 | 541.9 | 600.1 | 641.1 | 682.1 | 678.2 | 610.9 | 806.2 | 837.8 | 736.2 |
% effective tax rate | 61.6 21.6% | 72.6 26.4% | 40.8 15.5% | 55.1 17.1% | 49.7 13.4% | 63.3 16.4% | 56.1 12.8% | 76.3 15.0% | 26.2 5.4% | 40.1 8.2% | 59.1 12.0% | 72.9 13.4% | 78.6 13.1% | 620.8 96.8% | 88.4 13.0% | 86.0 12.7% | 89.3 14.6% | 113.4 14.1% | 130.1 15.5% | 94.0 12.8% |
% margin | 224.1 20.3% | 202.0 17.4% | 222.2 17.4% | 268.1 18.2% | 322.5 20.5% | 323.3 21.6% | 381.8 23.2% | 433.0 23.4% | 461.4 25.0% | 450.0 23.6% | 431.6 21.7% | 469.1 23.0% | 521.5 24.1% | 20.3 0.9% | 593.8 24.5% | 592.2 24.6% | 521.6 22.1% | 692.8 24.9% | 707.8 23.8% | 642.2 21.7% |
| EPS | 1.87 | 1.77 | 2.16 | 2.67 | 3.25 | 3.37 | 4.13 | 4.77 | 5.25 | 5.27 | 5.12 | 5.70 | 6.46 | 0.25 | 7.71 | 8.76 | 8.40 | 11.25 | 11.80 | 10.87 |
| Diluted EPS | 1.82 | 1.74 | 2.13 | 2.62 | 3.21 | 3.34 | 4.06 | 4.69 | 5.19 | 5.20 | 5.07 | 5.65 | 6.41 | 0.25 | 7.65 | 8.69 | 8.36 | 11.17 | 11.73 | 10.84 |
% margin | 337.7 30.6% | 326.8 28.2% | 360.8 28.2% | 402.2 27.3% | 476.0 30.2% | 454.9 30.4% | 514.3 31.3% | 597.6 32.3% | 584.5 31.7% | 597.0 31.4% | 638.3 32.1% | 668.2 32.7% | 725.0 33.5% | 784.0 34.0% | 799.6 33.0% | 822.1 34.2% | 778.0 32.9% | 958.4 34.4% | 1,014.1 34.1% | 1,001.0 33.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Waters Corporation's P/EBITDA LTM?
As of today, Microsoft Corp's last 12-month P/EBITDA LTM is 21.1x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/EBITDA LTM for Waters Corporation have been 19.8x over the past three years, and 20.0x over the past five years.
2) Is Waters Corporation's P/EBITDA LTM Good?
As of today, Waters Corporation's P/EBITDA LTM is 21.1x, which is higher than industry median of (0.7x). It indicates that Waters Corporation's P/EBITDA LTM is Bad.